US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CRO Concept

2,048.74

-9.6951-0.47%

Number of Gainers:- -

Number of Losers:2

Number of Flat:1

PE:- -

High:2,060.81

Open:2,058.06

Low:2,010.33

Close:2,058.43

Volume:2.89M

Turnover:674.34M

Market Cap:51.95B

Float Cap:49.74B

Loading ...

Charles River Laboratories: Overdone CEO-Transition Selloff Creates Attractive Entry Point Amid Improving Fundamentals

Iqvia price target raised to $280 from $250 at UBS

BRIEF-Charles River Laboratories Announces Planned Retirement Of James C. Foster

Charles River Laboratories Names Birgit Girshick as Next CEO

Charles River Laboratories International Inc: Birgit Girshick Unanimously Appointed Next Chief Executive Officer, Also Effective in May 2026

THOMSON REUTERS

Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

THOMSON REUTERS

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":2048.7385,"timestamp":1767905999999,"preClose":2058.4336,"halted":0,"volume":2889549,"delay":0,"changeRate":-0.00471,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-9.695068,"latestTime":"01-08 16:00:00 EST","open":2058.0647,"high":2060.8062,"low":2010.3325,"amount":674340413.767933,"amplitude":0.02452,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767969000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.394228,"peRate":42.972657,"turnoverRate":0.013754,"increases":0,"decrements":2,"flats":0,"marketCap":51948726272,"floatMarketCap":49744823296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":2060.8062,"amplitude":0.02452,"preClose":2058.4336,"low":2010.3325,"pbRate":"5.394228","latestPrice":2048.7385,"volume":2889549,"delay":0,"open":2058.0647,"prevYearClose":1899.2574,"prevWeekClose":1904.5244,"prevMonthClose":1899.2574,"prevQuarterClose":1899.2574,"fiveDayClose":1899.2574,"twentyDayClose":1823.1167,"sixtyDayClose":1697.0664,"secType":"PLATE","market":"US","turnoverRate":0.013754,"peRate":42.972657,"marketCap":51948726272,"floatMarketCap":49744823296,"timestamp":1767905999999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":0,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602396397","title":"Charles River Laboratories: Overdone CEO-Transition Selloff Creates Attractive Entry Point Amid Improving Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2602396397","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602396397?lang=en_us&edition=fundamental","pubTime":"2026-01-08 23:46","pubTimestamp":1767887172,"startTime":"0","endTime":"0","summary":"William Blair analyst Max Smock has reiterated their bullish stance on CRL stock, giving a Buy rating on January 2. Max Smock has given his Buy rat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/charles-river-laboratories-overdone-ceo-transition-selloff-creates-attractive-entry-point-amid-improving-fundamentals-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/charles-river-laboratories-overdone-ceo-transition-selloff-creates-attractive-entry-point-amid-improving-fundamentals-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1815336091.USD","LU0029874061.USD","CRL","BK4588","LU0390134368.USD","BK4530","IE00BFMHRM44.USD","BK4121","LU0128526141.USD","BK4585","LU0757428866.USD"],"gpt_icon":0},{"id":"2601362042","title":"Iqvia price target raised to $280 from $250 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362042?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:36","pubTimestamp":1767879384,"startTime":"0","endTime":"0","summary":"UBS analyst Dan Leonard raised the firm’s price target on Iqvia (IQV) to $280 from $250 and keeps a Buy rating on the shares. Published first on Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iqvia-price-target-raised-to-280-from-250-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iqvia-price-target-raised-to-280-from-250-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQV","LU1261432733.SGD","LU0477156797.USD","BK4588","IE0034235071.USD","BK4118","LU1863844665.USD","BK4585","LU1863844749.USD","BK4534","LU0882574055.USD","LU1791710400.SGD","LU0648000940.SGD","LU1201861165.SGD","UBS","LU1989764748.USD","LU0130102774.USD","LU3187612489.SGD","LU1201861249.SGD","LU0130518102.USD","LU1829250122.USD","LU0528227936.USD","LU0198837287.USD","LU0980610538.SGD","LU0477156953.USD","BK4530","LU1791710582.SGD","BK4121","LU0130517989.USD","LU0648001328.SGD","LU0130103400.USD","LU1989764664.SGD"],"gpt_icon":0},{"id":"2601625263","title":"BRIEF-Charles River Laboratories Announces Planned Retirement Of James C. Foster","url":"https://stock-news.laohu8.com/highlight/detail?id=2601625263","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601625263?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:25","pubTimestamp":1767878738,"startTime":"0","endTime":"0","summary":"BRIEF-Charles River Laboratories Announces Planned Retirement Of James C. Foster Jan 8 (Reuters) - Charles River Laboratories International Inc CRL.N:CHARLES RIVER LABORATORIES ANNOUNCES PLANNED RETIR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUACGH178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4121","LU0029874061.USD","LU0757428866.USD","LU0128526141.USD","BK4588","LU0390134368.USD","IE00BFMHRM44.USD","BK4585","LU1815336091.USD","CRL"],"gpt_icon":0},{"id":"2601310364","title":"Charles River Laboratories Names Birgit Girshick as Next CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2601310364","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601310364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:01","pubTimestamp":1767877309,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International Inc. announced that James C. Foster will retire as Chair, President, and CEO at the conclusion of the 2026 Annual Meeting of Shareholders. Birgit Girshick, currently Executive Vice President and Chief Operating Officer, has been appointed to succeed Foster as CEO, effective May 2026, and will also be nominated to join the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL4Y2Vmm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4585","IE00BFMHRM44.USD","LU0128526141.USD","BK4530","BK4588","BK4121","LU1815336091.USD","CRL","LU0029874061.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2601648963","title":"Charles River Laboratories International Inc: Birgit Girshick Unanimously Appointed Next Chief Executive Officer, Also Effective in May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601648963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601648963?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUACGH178:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRL","BK4585","LU0029874061.USD","LU0390134368.USD","LU0757428866.USD","BK4530","IE00BFMHRM44.USD","LU1815336091.USD","BK4121","LU0128526141.USD","BK4588"],"gpt_icon":0},{"id":"2601364823","title":"Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364823","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364823?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUACGH178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","IE00BFMHRM44.USD","BK4585","BK4588","LU1815336091.USD","LU0390134368.USD","BK4530","CRL","LU0757428866.USD","LU0029874061.USD","LU0128526141.USD"],"gpt_icon":0},{"id":"2601131845","title":"Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2601131845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601131845?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:07","pubTimestamp":1767737220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  rose 4.02% to $180.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.62% to 6,944.82 and the Dow Jones Industrial Average  rising 0.99% to 49,462.08.Quest Diagnostics Inc. closed 8.65% short of its 52-week high of $197.55, which the company achieved on October 21st.The stock outperformed some of its competitors Tuesday, as UnitedHealth Group Inc.  rose 2.03% to $348.97, IQVIA Holdings Inc.  rose 2.53% to $240.53, and Centene Corp.  rose 2.37% to $45.74.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled January 6, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154935.USD","IE0009355771.USD","LU0251132253.USD","LU0823417653.USD","LU0976567544.SGD","LU1201861249.SGD","LU0130518102.USD","LU0238689110.USD","IE00BZ1G4Q59.USD","LU1732800096.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0477156953.USD","IE00B19Z9Z06.USD","BK4566","LU2361044865.SGD","LU1119994496.HKD","LU2279689827.SGD","LU1323610961.USD","BK4585","LU0048584097.USD","IE00BSNM7G36.USD","LU0912757837.SGD","SG9999001176.USD","LU2028103732.USD","LU1084165304.USD","LU1732799900.SGD","LU1670628061.USD","IE00BWXC8680.SGD","IE00BZ9MQY76.HKD","LU0708994859.HKD","LU1718418525.SGD","DGX","LU1983299246.USD","LU2506952170.USD","LU0417517546.SGD","LU1791710582.SGD","LU0149725797.USD","IE0034235188.USD","IE00BKPKM429.USD","LU0648000940.SGD","IE00BFTCPJ56.SGD","LU2271345857.HKD","LU0882574055.USD","LU2552382215.SGD","BK4583","LU0310799852.SGD","LU1037948541.HKD","LU0130103400.USD","LU0965509283.SGD","IE00B19Z8X17.USD","LU0795875086.SGD","LU2506951958.HKD","LU0943347566.SGD","SGXZ31699556.SGD","LU0310800379.SGD","LU0316494557.USD","LU0545039389.USD","LU1291159041.SGD","LU2089284900.SGD","LU0211328371.USD","LU0557290698.USD","LU2112291526.USD","IE00B894F039.SGD","LU2244417387.USD","LU0795875169.SGD","IE00B19Z9505.USD","IE00BKVL7J92.USD","LU0320765059.SGD","LU2357305700.SGD","LU1066051811.HKD","LU0980610538.SGD","SG9999018857.SGD","LU0107464264.USD","LU0198837287.USD","LU1699723380.USD","SG9999002224.SGD","SG9999017495.SGD","LU0672654240.SGD","LU1201861165.SGD","LU1548497426.USD","LU2361044949.HKD","LU1153585028.USD","LU1551013342.USD","IE00B19Z3B42.SGD","LU1814569148.SGD","IE00BFXG1179.USD","LU2461242641.AUD","LU1069347547.HKD","LU0354030438.USD","BK4196","LU0861579265.USD","BK4588","BK4533","LU0077335932.USD","LU1037948897.HKD","LU1023059063.AUD","BK4530","IE00B775H168.HKD","LU1674673691.USD","LU2324357040.USD","SG9999002232.USD","IE0002141913.USD","BK4581","LU0211327993.USD","LU2360032135.SGD","LU2552382058.USD","SGXZ57979304.SGD","SGXZ99366536.SGD","LU0683600562.USD","LU0949170772.SGD","LU0266013472.USD","LU2552382132.HKD","LU1854104046.USD","LU1261432733.SGD","LU2089984988.USD","LU1989771016.USD","LU0823417737.USD","LU1267930730.SGD","LU1934455194.USD","LU0109391861.USD","IE0005OL40V9.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU1989764664.SGD","LU1934455863.HKD","LU0353189763.USD","IE00B1BXHZ80.USD","LU2125154778.USD","LU2236285917.USD","BK4534","LU1551013425.SGD","SG9999014880.SGD","IE00BJJMRY28.SGD","LU2242649171.HKD","SG9999014898.SGD","IE0004445015.USD","LU0114720955.EUR","LU2362540622.SGD","LU1267930573.SGD","LU2362541273.HKD","LU1074936037.SGD","LU0122379950.USD","IE00B7SZLL34.SGD","BK4154","IE00B4JS1V06.HKD","LU1267930227.SGD","SG9999014914.USD","LU0128525689.USD","LU1854103824.USD","LU2211815571.USD","LU0052756011.USD","LU0496365809.HKD","LU1674673428.USD","LU1061106388.HKD","LU1791710400.SGD","SG9999014906.USD","LU0787776722.HKD","LU0130102774.USD","LU0708995401.HKD","LU0342679015.USD","LU1670627923.USD","LU1064131342.USD","LU1934455277.USD","LU1914381329.SGD","LU0211326755.USD","LU0820561909.HKD","LU2361045086.USD","IE00B19Z9P08.USD","LU0345770308.USD","LU0079474960.USD","LU0203347892.USD","IE00B19Z8W00.USD","LU0432979614.USD","LU2133065610.SGD","IE00B7KXQ091.USD","LU1989764748.USD","LU0553294199.USD","LU2491049909.HKD","LU2506951875.HKD","LU0029864427.USD","LU0094547139.USD","IE00BN29S564.USD","IE00B2B36J28.USD","IE0004445239.USD","LU2506952097.USD","LU0661504455.SGD","IE00BJT1NW94.SGD","LU0353189680.USD","LU0820561818.USD","LU0097036916.USD","LU1035773651.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU1066051498.USD","LU0965509010.AUD","LU1988902786.USD","LU2491050154.USD","LU0965508806.USD","LU0528227936.USD","LU1066051225.USD","SGXZ51526630.SGD","LU0456855351.SGD","LU2264538146.SGD","LU0158827781.USD","LU0158827948.USD","LU1720051017.SGD","LU1720051108.HKD","LU0310800965.SGD","LU2023251221.USD","LU0256863811.USD","LU2362541513.USD","IE0002270589.USD","LU0648001328.SGD","LU2347655156.SGD","SG9999018865.SGD","IE00B4R5TH58.HKD","LU0130517989.USD","LU1778281490.HKD","LU0354030511.USD","LU0187121727.USD","IE00BJJMRX11.SGD","LU0289739699.SGD","LU0689472784.USD","LU0211326839.USD","LU1267930490.SGD","LU1066053197.SGD","SG9999013999.USD","BK4567","SG9999001176.SGD","LU0234572021.USD","LU2491050071.SGD","LU0950375773.USD","LU2111349929.HKD","BK4121","SGXZ81514606.USD","LU0345770993.USD","LU1003077747.HKD","LU0203345920.USD","LU0011850046.USD","LU2087625088.SGD","LU0738911758.USD","IE00BFSS7M15.SGD","LU0477156797.USD","LU0965509101.SGD","BK4532","LU0820562030.AUD","LU0823416689.USD","LU1496350502.SGD","LU1057294990.SGD","LU1506573853.SGD","LU0128525929.USD","LU0053666078.USD","IE00BFSS8Q28.SGD","LU2089283258.USD"],"gpt_icon":0},{"id":"2601186358","title":"FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2601186358","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601186358?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:54","pubTimestamp":1767707640,"startTime":"0","endTime":"0","summary":"The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to show a favorable benefit-risk balance for any patient group.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/06/Gentilly--France--March-21--2021-Sign-An.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/06/Gentilly--France--March-21--2021-Sign-An.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/01/49721626/fda-flags-liver-injury-risk-in-sanofis-rejected-multiple-sclerosis-drug","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/01/49721626/fda-flags-liver-injury-risk-in-sanofis-rejected-multiple-sclerosis-drug","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4588","CRL","LU0390134368.USD","SNYNF","BK4585","IE00BFXG1179.USD","LU0757428866.USD","SNY","LU1815336091.USD","BK4530","BK4121","LU0128526141.USD","BK4007","LU0029874061.USD","IE00BFMHRM44.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}